Semaglutide 2.4mg in Australia: Patient Information
General patient information about semaglutide 2.4mg (the active ingredient in the brand Wegovy), a prescription-only weight-management medicine in Australia. Not an advertisement and not medical advice.
Important context
Healthcare prices can change without notice and may exclude consultation fees, medication, diagnostics, anaesthetic, facility fees, follow-up care or add-ons. TreatCompare summarises published or compiled pricing for comparison and planning only. Always verify the current total directly before paying.
- Source type
- TreatCompare compiled research
- Primary source
- Provider-published information and TreatCompare research
- Reporting period
- 2026-05-12
- Last updated
- 2026-05-12
- Figure type
- Mixed sources
- Use
- Research and comparison only
Are you a clinic, provider or data owner?
If you believe information on this page is inaccurate, out of date, incomplete or presented without necessary context, contact us with the page URL and supporting evidence. We review correction requests promptly, but they are not automatically accepted.
Australia hub
Australia healthcare cost guides
How this guide was checked
TreatCompare uses published provider fees, official regulator registers, NHS/PBS/Medicare references where relevant, and the methodology described on our methodology page. If a clinic, provider or reader spots information that is out of date, they can use our corrections page. Prices are point-in-time and can change before booking.
Most useful next step
Compare current Weight Loss options
This guide explains the costs. The Australia comparison pages show local prices, Medicare/PBS rules and next actions.
Continue from this guide
Turn this Weight Loss article into a comparison
Article visitors often need one of three routes next: provider prices, a calculator, or a related guide that narrows the decision.
Important information for Australian consumers. Semaglutide 2.4mg is a prescription-only (Schedule 4) medicine in Australia, supplied under the brand name Wegovy. Australian regulations restrict the advertising of prescription medicines to consumers, so this article is general patient information — it is not an advertisement, not an offer of sale, and not medical advice. Whether semaglutide 2.4mg is clinically appropriate for you is a decision for an AHPRA-registered prescriber following an assessment.
This article is a short patient-information landing. For the full patient information — TGA-approved indication, what to discuss with an AHPRA-registered prescriber, PBS context and the service-level cost components of a private consultation — see Semaglutide 2.4mg in Australia — Patient Information. For consumer information about Australian weight-management treatment more generally, see the weight-management hub.
What this article does not do
This article does not list semaglutide 2.4mg prices, compare it to other medicines on price, list provider pricing for it, or recommend a buying pathway. The medicine itself is priced by the dispensing pharmacy.
If you have spotted an error
Please tell us via the corrections route.
Australia hub
Australia healthcare cost guides
Frequently asked questions
What is semaglutide 2.4mg?
Semaglutide 2.4mg is a prescription-only (Schedule 4) medicine in Australia, supplied under the brand name Wegovy. It is TGA-approved for weight management in adults who meet the clinical criteria set out in its Australian Register of Therapeutic Goods entry. A separate semaglutide product (Ozempic) is TGA-approved for type 2 diabetes only.
Is semaglutide 2.4mg PBS-subsidised for weight management?
Semaglutide 2.4mg is not currently PBS-subsidised for weight management in Australia. The cost of the medicine is generally paid privately. PBS schedules change; check pbs.gov.au for current status.
Why does this page not list semaglutide 2.4mg prices?
Australian regulations restrict the advertising of prescription medicines to consumers. Pairing a brand name and price in a consumer context is treated as advertising under the TGA Therapeutic Goods Advertising Code, so TreatCompare does not display Australian prescription-medicine prices.
Get an email when prices change
Free alerts when a new provider lists, or the cheapest published price falls. Confirm by email; unsubscribe in one click.
We'll send a confirmation link first. No marketing — alerts only. Unsubscribe with one click in any email.
Compare prices from verified providers
Weight Loss Injection Prices
Compare Mounjaro, Wegovy, Ozempic, and Nevolat prices from verified GPhC-registered UK pharmacies. Checked weekly.
Related articles
GLP-1 Weight-Management Medicines in the UK: Patient Information (2026)
Patient information about the GLP-1 receptor agonists used for weight management or type 2 diabetes in the UK — Mounjaro, Wegovy, Ozempic, Rybelsus, Nevolat. No prescription-medicine prices.
How to Get Mounjaro in the UK: Patient Information (2026)
Patient information about UK NHS and private routes for Mounjaro (tirzepatide). Not an advertisement and not medical advice.
Mounjaro in the UK: Patient Information
General patient information about Mounjaro (tirzepatide) in the UK and the service-level cost components of a UK private weight-management consultation. Not an advertisement and not medical advice.
Mounjaro Maintenance Dose in the UK: Patient Information
General patient information about the Mounjaro (tirzepatide) maintenance-dose phase in the UK. Not an advertisement and not medical advice.